CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $63,942,807
- in 12 filings, $45.5M under 10b5-1 plans
Net −$63,942,807. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-20 | Humes Jennifer Chief Accounting Officer | Shares withheld for taxes | −3,880 | $39.77 | $154K | 106,419 |
| 2026-06-20 | Humes Jennifer Chief Accounting Officer | Shares withheld for taxes | −3,582 | $31.43 | $113K | 109,782 |
| 2026-04-20 | Humes Jennifer Chief Accounting Officer | Grant or award | +29,173 | 113,364 | ||
| 2026-04-20 | Humes Jennifer Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +27,157 | 27,157 | ||
| 2026-04-08 | Humes Jennifer Chief Accounting Officer | Sale | −13,538 | $28.37 | $384K | 84,191 |
| 2026-03-20 | Humes Jennifer Chief Accounting Officer | Shares withheld for taxes | −14,526 | $27.70 | $402K | 97,729 |
| 2025-03-20 | Humes Jennifer Chief Accounting Officer | Grant or award | +112,255 | 112,255 | ||
| 2025-03-20 | Humes Jennifer Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +115,108 | 115,108 |
Page 1 of 1 · 8 trades